Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease

被引:54
作者
Arcaini, Luca
Paulli, Marco
Burcheri, Sara
Rossi, Andrea
Spina, Michele
Passamonti, Francesco
Lucioni, Marco
Motta, Teresio
Canzonieri, Vincenzo
Montanari, Mauro
Bonoldi, Emanuela
Gallamini, Andrea
Uziel, Lilj
Crugnola, Monica
Ramponi, Antonio
Montanari, Francesca
Pascutto, Cristiana
Morra, Enrica
Lazzarino, Mario
机构
[1] Univ Pavia, Div Haematol, Fdn IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, Div Pathol, Fdn IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[3] Osped Riuniti Bergamo, Div Haematol, I-24100 Bergamo, Italy
[4] Osped Riuniti Bergamo, Div Pathol, I-24100 Bergamo, Italy
[5] Natl Canc Inst, Div Med Oncol A, Aviano, Italy
[6] Natl Canc Inst, Dept Pathol, Aviano, Italy
[7] Univ Ancona, Div Haematol, Ancona, Italy
[8] Osped S Bortolo, Dept Pathol, Vicenza, Italy
[9] Osped S Croce, Div Haematol, Cuneo, Italy
[10] Osped San Paolo, Div Oncol, Milan, Italy
[11] Univ Parma, Div Haematol, I-43100 Parma, Italy
[12] AO Maggiore Car, Dept Pathol, Novara, Italy
[13] Osped Niguarda Ca Granda, Div Haematol, Milan, Italy
关键词
nodal marginal zone lymphoma; low-grade non-Hodgkin lymphoma; marginal zone; prognosis; hepatitis C virus;
D O I
10.1111/j.1365-2141.2006.06437.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study defined the clinical features and assessed the prognosis of 47 patients (17 males, 30 females, median age 63 years) with primary nodal marginal zone B-cell lymphoma. Forty-five per cent had stage IV disease. Hepatitis C virus serology was positive in 24%. According to the Follicular Lymphoma International Prognostic Index (FLIPI), 33% were classified as low-risk, 34% as intermediate-risk, and 33% as high-risk. The 5-year overall survival (OS) was 69%. In univariate analysis worse OS was associated with: FLIPI (P = 0.02), age > 60 years (P = 0.05) and raised lactate dehydrogenase (P = 0.05). In multivariate analysis, only FLIPI predicted a worse OS (P = 0.02).
引用
收藏
页码:301 / 304
页数:4
相关论文
共 12 条
[1]   Splenic marginal zone lymphoma: a prognostic model for clinical use [J].
Arcaini, Luca ;
Lazzarino, Mario ;
Colombo, Nora ;
Burcheri, Sara ;
Boveri, Emanuela ;
Paulli, Marco ;
Morra, Enrica ;
Gambacorta, Marcello ;
Cortelazzo, Sergio ;
Tucci, Alessandra ;
Ungari, Marco ;
Ambrosetti, Achille ;
Menestrina, Fabio ;
Orsucci, Lorella ;
Novero, Domenico ;
Pulsoni, Alessandro ;
Frezzato, Maurizio ;
Gaidano, Gianluca ;
Vallisa, Daniele ;
Minardi, Viviana ;
Tripodo, Claudio ;
Callea, Vincenzo ;
Baldini, Luca ;
Merli, Francesco ;
Federico, Massimo ;
Franco, Vito ;
Iannitto, Emilio .
BLOOD, 2006, 107 (12) :4643-4649
[2]   New approach to classifying non-hodgkin's lymphomas: Clinical features of the major histologic subtypes [J].
Armitage, JO ;
Weisenburger, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2780-2795
[3]   Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients [J].
Berger, F ;
Felman, P ;
Thieblemont, C ;
Pradier, T ;
Baseggio, L ;
Bryon, PA ;
Salles, G ;
Callet-Bauchu, E ;
Coiffier, B .
BLOOD, 2000, 95 (06) :1950-1956
[4]   Nodal marginal zone lymphoma:: A heterogeneous tumor -: A comprehensive analysis of a series of 27 cases [J].
Camacho, FI ;
Algara, P ;
Mollejo, M ;
García, JF ;
Montalbán, C ;
Martínez, N ;
Sánchez-Beato, M ;
Piris, MA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :762-771
[5]   Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes [J].
Conconi, A ;
Bertoni, F ;
Pedrinis, E ;
Motta, T ;
Roggero, E ;
Luminari, S ;
Capella, C ;
Bonato, M ;
Cavalli, F ;
Zucca, E .
BLOOD, 2001, 98 (03) :781-786
[6]   A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].
FISHER, RI ;
DAHLBERG, S ;
NATHWANI, BN ;
BANKS, PM ;
MILLER, TP ;
GROGAN, TM .
BLOOD, 1995, 85 (04) :1075-1082
[7]  
HARRIS NL, 1994, BLOOD, V84, P1361
[8]  
JAFFE ES, 2001, WHO CLASSIFICATION T, P135
[9]   Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma [J].
Marasca, R ;
Vaccari, P ;
Luppi, M ;
Zucchini, P ;
Castelli, I ;
Barozzi, P ;
Cuoghi, A ;
Torelli, G .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :253-261
[10]   Marginal zone B-cell lymphoma:: A clinical comparison of nodal and mucosa-associated lymphoid tissue types [J].
Nathwani, BN ;
Anderson, JR ;
Armitage, JO ;
Cavalli, F ;
Diebold, J ;
Drachenberg, MR ;
Harris, NL ;
MacLennan, KA ;
Müller-Hermelink, HK ;
Ullrich, FA ;
Weisenburger, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2486-2492